Orion Pharma Limited reported earnings results for the third quarter and nine months ended March 31, 2024. For the third quarter, the company reported sales was BDT 2,035.3 million compared to BDT 2,297.65 million a year ago. Net income was BDT 99.22 million compared to BDT 123.87 million a year ago. Basic earnings per share from continuing operations was BDT 0.42 compared to BDT 0.53 a year ago.
For the nine months, sales was BDT 7,780.5 million compared to BDT 10,210.82 million a year ago. Net income was BDT 386.13 million compared to BDT 571.62 million a year ago. Basic earnings per share from continuing operations was BDT 1.65 compared to BDT 2.44 a year ago.